STERIS AST provides contract sterilization, laboratory testing, and product and packaging testing services to medical device and pharmaceutical manufacturers.

STERIS AST

Apollo Endosurgery develops devices that advance therapeutic endoscopy, focusing on alternatives to invasive surgical procedures to improve patient lives.

Apollo Endosurgery

Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations and accountable care organizations. It offers end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.

James B. Powell

Laboratory Corporation of America Holdings

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Metric
Company Name	STERIS AST	Apollo Endosurgery	Laboratory Corporation of America Holdings	Quest Diagnostics Incorporated
Symbol			LH	DGX
MSH ID	COM:STERIS-AST	COM:APOLLOENDO	COM:LABCORP	COM:QUESTDIAGNOSTICS
Market	PRIVATE	PRIVATE	STOCKS	STOCKS
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare	Healthcare
Industry	Medical Device and Pharmaceutical Services	Medical Devices	Medical - Diagnostics & Research	Medical - Diagnostics & Research
Country	US	US	US	US
Stage		Post-IPO Debt
Employee Count			67K	50K
Website	steris-ast.com	apolloendo.com	labcorp.com	questdiagnostics.com
LinkedIn				quest-diagnostics
Founders

Metric
Market Cap		16.89B	15.60B
Enterprise Value
Monthly Web Traffic	4.86K		17.21M
Web Traffic Growth	0.32		0.14
Valuation
Raised Capital	35M		1.85B

Metric
Revenue	12.16B	9.25B
Revenue (LTM)
Revenue (NTM)
Gross Profit	3.15B	3.05B
EBITDA	1.70B	1.26B
Operating Income	1.12B	1.26B
Net Income	418M	854M
EPS	4.80	7.63
Diluted EPS	4.77	7.56
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.27	0.33
Operating Profit Margin	0.09	0.14
EBITDA Margin	0.14	0.14
Net Profit Margin	0.04	0.09
Return on Equity	0.06	0.14
Return on Assets	0.03	0.06
Return on Capital Employed	0.09	0.11

COM:STERIS-AST

STERIS AST

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	28.87	16.23
P/B Ratio	2.42	2.20
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	1.59	1.87
EV Multiple	8.77	7.06

Metric
Days Sales Outstanding	55.66	47.74
Days Payables Outstanding	25.45
Days Inventory Outstanding	19.25	11.19
Operating Cycle	84.65	62.53
Cash Conversion Cycle	52.97	62.07
Asset Turnover	0.77	0.67

Metric
Operating Cash Flow	1.33B	1.27B
Free Cash Flow	874.10M	864M
Cash Flow to Debt	0.26	0.27
Operating Cash Flow/Sales	0.11	0.14
Free Cash Flow Yield	0.05	0.04

Metric
Cash & Equivalents	536.80M	686M
Accounts Receivable	-75.30M	-15M
Inventory	474.60M	190M
Goodwill	6.14B	7.73B
Debt to Capitalization	0.43	0.44
Debt to Assets	0.37	0.38
Current Ratio	1.36	1.31
Quick Ratio	0.82	1.04

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.01	0.01
R&D to Revenue
SG&A to Revenue